Tutti gli studi
ReclutamentoOSSERVAZIONALE

Studio Osservazionale di Adulti e Adolescenti con Protoporfiria Eritropoietica (EPP) e Porfiria X-linked (XLP)

This study aims to understand more about Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP) in people aged 12 and older. It's an observational study, which means participants won't receive a new treatment or medication. Instead, researchers will gather information about how these conditions affect daily life and health. This will involve regular visits over six months to check symptoms, take blood samples, measure vital signs, and possibly wear a device to track light exposure. Participants will also keep a daily diary of their symptoms. The goal is to collect important data that could help improve our understanding and care for people with EPP and XLP.

A colpo d'occhio

Stato
Reclutamento
Sponsor
Portal Therapeutics, Inc.
Obiettivo di iscrizione
50
Inizio
30 Apr 2026
Completamento stimato
01 Apr 2027

Di cosa tratta questo studio?

This study focuses on two rare conditions called Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP). If you or someone you know has been diagnosed with one of these conditions, you might be familiar with the challenges they can bring, especially related to sun exposure. The main purpose of this research is to collect detailed information about how these conditions affect adults and teenagers in their everyday lives.

It's important to know that this isn't a study where you'll try a new medicine or treatment. Instead, it's an 'observational' study. This means the researchers will simply observe and record information about your condition as it is, without changing your current care. By carefully collecting these details from many people, scientists can gain a much clearer picture of EPP and XLP.

The information gathered will help doctors and researchers understand the conditions better, which could eventually lead to improved ways to diagnose, manage, and care for people living with EPP and XLP in the future. Your participation could make a real difference in advancing our knowledge.

Punti chiave

  • Study collects information on EPP/XLP in ages 12 and up.
  • It's an observational study; no new treatments are given.
  • Participation involves periodic visits and symptom diaries over 6 months.
  • Helps researchers understand EPP/XLP better, potentially improving future care.
  • Puoi ritirarti dallo studio in qualsiasi momento.

Chi può essere idoneo?

To join this study, you need to be at least 12 years old and have a confirmed diagnosis of EPP or XLP. This diagnosis might be based on genetic tests showing specific changes in your genes, or on blood tests that show high levels of a substance called PPIX, along with your symptoms and family history.

You should currently be experiencing symptoms of EPP or XLP. A key part of this is having a history of feeling a consistent, non-painful sensation within about 45 minutes of sun exposure, just before you experience more severe skin reactions. You also need to be willing to participate fully, which includes wearing a special device that measures light, keeping a daily diary of your symptoms, and covering certain areas of your skin when asked for specific tests.

Questo studio potrebbe fare al caso tuo?

Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.

  1. Are you 12 years old or older?
  2. Do you have a confirmed diagnosis of EPP or XLP?
  3. Are you currently experiencing symptoms related to EPP/XLP?
  4. Do you have a history of feeling early, mild symptoms before sun-related skin reactions?
  5. Are you willing to wear a light-measuring device and keep a daily symptom diary?
Rispondi a ogni domanda per vedere il tuo risultato.

Cosa comporta la partecipazione?

If you decide to take part, the study will last for up to 6 months. After an initial screening, you'll have a first main visit (called Baseline Day 1). Over the next 24 weeks, you'll come back for follow-up visits every 4 weeks.

During these visits and at home, you'll be asked to do several things. This includes having standard checks like physical exams, measuring your blood pressure and heart rate (vital signs), and giving blood samples to check certain levels in your blood. You might also be asked to wear a device that measures the amount of light you're exposed to. A very important part of the study is keeping a daily diary to record your EPP/XLP-related symptoms. It's also possible you may need to keep certain skin areas covered before specific tests, as explained by the study team. You won't receive any new treatments as part of this study.

Rischi e benefici potenziali

Participating in this study might not directly benefit your health immediately, as it doesn't involve new treatments. However, the information gathered could significantly help future patients by improving our overall understanding of EPP and XLP. Potential risks are generally low, mainly involving the inconvenience of regular visits, blood draws which can cause minor bruising or discomfort, and the time commitment for daily diary entries. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (19)

  • Massachusetts General Hospital
    Codice postale verificato
    Boston, Stati Uniti· Reclutamento
  • Mount Sinai School of Medicine
    Codice postale verificato
    New York, Stati Uniti· Reclutamento
  • Wake Forest University Baptist Health - Dept of Gastroenterology
    Codice postale verificato
    Wake Forest, United States· Reclutamento
  • Temple University
    Codice postale verificato
    Philadelphia, Stati Uniti· Non ancora in fase di reclutamento
  • University of Texas Health - Ertan Digestive Disease Center
    Codice postale verificato
    Houston, Stati Uniti· Reclutamento
  • UZ Leuven
    Codice postale verificato
    Lovanio, Belgio· Non ancora in fase di reclutamento
  • University of Alberta Hospital
    Codice postale verificato
    Edmonton, Canada· Non ancora in fase di reclutamento
  • Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - Andre
    Codice postale verificato
    Bordeaux, Francia· Non ancora in fase di reclutamento
  • AP-HP Hopital Bichat - Claude Bernard
    Codice postale verificato
    Parigi, Francia· Non ancora in fase di reclutamento
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano
    Codice postale verificato
    Milano, Italia· Non ancora in fase di reclutamento
  • Azienda Ospedaliero-Universitaria di Modena
    Codice postale verificato
    Modena, Italy· Non ancora in fase di reclutamento
  • Haukeland University Hospital
    Codice postale verificato
    Bergen, Norway· Non ancora in fase di reclutamento

Domande comuni

Che cos'è uno studio 'osservazionale'?

An observational study means researchers watch and collect information about your condition without giving you any new treatments or medicines. They just observe what is already happening.

Will I receive new medicine in this study?

No, this study is about collecting information only. You will not be given any new treatments or medications as part of your participation.

Quanto tempo dovrò rimanere nello studio?

The study will last for up to 6 months for each person who takes part.

Che tipo di test avrò?

You'll have physical exams, blood tests, your vital signs (like blood pressure) checked, and you'll complete a daily diary. You might also wear a device that measures light.

Posso abbandonare lo studio se cambio idea?

Yes, you can decide to leave the study at any time, for any reason. It will not affect your usual medical care.

Come saperne di più

GondolaBio Inquiries

Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.

Interessato a partecipare?

Registrati per ricevere aggiornamenti

Condividi i tuoi dettagli e il team di ricerca per "Observational Study of Adults and Adolescents With Erythropo…" ti contatterà se potresti essere idoneo. Parla sempre con il tuo medico prima di accettare di partecipare.

Discussione

Discussione della comunità

Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.